BioSpace News Archive

Biotech Bay

Adverum Biotechnologies Reports New Interim Data from Cohorts 1 and 2 of OPTIC Phase 1 Trial of ADVM-022 Intravitreal Gene Therapy for Wet AMD at Angiogenesis, Exudation, and Degeneration 2020

Adverum Biotechnologies, Inc. announced new interim clinical data from the OPTIC Phase 1 dose-ranging clinical trial of ADVM-022 intravitreal injection gene therapy.

February 8, 2020
·
10 min read
Business

Government of Canada Repatriates Canadians and their families from the Epicentre of the 2019-nCoV Outbreak in China

Yesterday, we welcomed home 174 Canadians and their family members travelling on a Government of Canada-chartered plane, as well as 39 who travelled on a second flight led by the United States from Wuhan, China.

February 8, 2020
·
2 min read
Drug Development

Kodiak Sciences Announces Additional Safety, Efficacy and Durability Data from Ongoing Phase 1b Study of KSI-301 in Patients with Wet Age-Related Macular Degeneration, Diabetic Macular Edema and Retinal Vein Occlusion

Encouraging safety profile continues with zero cases of intraocular inflammation after 420 doses in 130 patients

February 8, 2020
·
7 min read
Pharm Country

EYLEA® (aflibercept) Injection Reduced Risk of Developing Vision-Threatening Events by 75% After Two Years in Patients with Diabetic Retinopathy

New data highlight importance of proactive EYLEA treatment as more than half of untreated patients in PANORAMA developed vision-threatening events over two years

February 8, 2020
·
17 min read